PhD: Antimicrobial Hydrogels & Phage Therapy

NZZone; Lavamünd; Vor Ort; EUR 63.000 - 74.000; Vollzeit

Zusammenfassung

Empa’s Biointerfaces Laboratory in St. Gallen invites applications for a PhD position focused on antimicrobial biomaterials, microbiology, and bacteriophage therapy.

You will join an interdisciplinary team developing living hydrogel systems for wound infections caused by antimicrobial-resistant bacteria and biofilms. The project aims to create injectable therapeutics by combining probiotics and bacteriophages to eradicate infections and promote tissue regeneration, with translational goals

Qualifikationen

• Master's degree in a relevant field (Biomaterials, Biomedical Engineering, Biotechnology, Microbiology, Molecular Biology, Chemistry).
• Strong interest in antimicrobial resistance, biomaterials, microbiology, or phage therapy.
• Experience in microbiology, biofilm research, biomaterials/hydrogels, molecular biology or synthetic biology, and bacteriophages.

Aufgaben

• Design and synthesis of injectable hydrogel systems.
• Encapsulation and controlled delivery of probiotics and bacteriophages.
• Engineering and characterization of phage-based antimicrobial strategies against pathogenic bacteria and biofilms.
• Characterization and optimization of hydrogel properties and biological functionality.
• Evaluation of tissue regeneration and the therapeutic potential of living therapeutics.
• Elucidation of mechanisms of action and investigation of antimicrobial resistance evolution.

Kenntnisse

Biomaterials

Biomedical Engineering

Biotechnology

Microbiology

Molecular Biology

Chemistry

Ausbildung

Master's degree in Biomaterials, Biomedical Engineering, Biotechnology, Microbiology, Molecular Biology, Chemistry

Jobbeschreibung

Empa’s Biointerfaces Laboratory in St. Gallen invites applications for a PhD position focused on antimicrobial biomaterials, microbiology, and bacteriophage therapy.

You will join an interdisciplinary team developing living hydrogel systems for wound infections caused by antimicrobial-resistant bacteria and biofilms. The project aims to create injectable therapeutics by combining probiotics and bacteriophages to eradicate infections and promote tissue regeneration, with translational goals